Startups
Edit
Kadmon, a Sanofi Company
https://kadmon.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 15.05.2025
Active
Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track record of successful drug development and commercialization. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Our late-stage product candidate, belumosudil, is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) in development for the treatment of inflammatory and fibrotic diseases. A pivotal study of belumosudil is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 study in systemic sclerosis. Kadmon is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. Our lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein in a Phase 1 clinical trial. Comments are no longer monitored.
Overview
Location
United States, New York
Employees
51-200
Total raised
$240M
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Vivo Capital | vivocapital.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 15, 2021 | The rise of the world’s most valuable, female-led startup | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content This single statistic changes how we view health care From Anthem Australian graphic... |
| Sep 15, 2021 | The rise of the world’s most valuable, female-led startup | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why marketers are adopting a scientific approach From Optimizely Australian graphic ... |
| Mar 25, 2021 | KADMON HOLDINGS, INC. Kadmon : Announces Trial-In-Progress Poster on KD033 at the 2021 American Association for Cancer Research Annual Meeting | Kadmon Announces Trial-In-Progress Poster on KD033 at the 2021 American Association for Cancer Research Annual Meeting March 25, 2021 NEW YORK, NY / ACCESSWIRE / March 25, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will p... |
| May 14, 2018 | Waksal's gene therapy spinoff MeiraGTx says it’s time to fly with an $86M IPO | Alexandria “Zandy” Forbes Three years after Sam Waksal’s Kadmon spun out its gene therapy tech into a startup called MeiraGTx, the New York-based biotech says it’s ready to come out to play on Nasdaq. Waksal, an ex-con once sente... |
| Oct 31, 2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $33 million in equity raised, closing out a $48 million Series E round The funding will bring Aileron candidate ALRN-6924 – a drug that works to activate a solid tumor suppressor protein called p53 – to clinical trial. The company says its ... |
| Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices fro... |
Reviews 0
FAQ about Kadmon, a Sanofi Company
How much funding has Kadmon, a Sanofi Company raised?
Kadmon, a Sanofi Company has raised $240M in total across 1 funding round.
Who has invested in Kadmon, a Sanofi Company?
Parsers VC lists 2 investors of Kadmon, a Sanofi Company, among them Vivo Capital.
What has the press written about Kadmon, a Sanofi Company?
Parsers VC has collected 7 articles mentioning Kadmon, a Sanofi Company, among them “The rise of the world’s most valuable, female-led startup” (Sep 15, 2021) and “The rise of the world’s most valuable, female-led startup” (Sep 15, 2021).
Is Kadmon, a Sanofi Company still active?
Yes, Kadmon, a Sanofi Company is active; its latest activity on Parsers VC dates from May 15, 2025.